Two Sigma Investments LP Purchases Shares of 45,293 LifeStance Health Group, Inc. (NASDAQ:LFST)

Two Sigma Investments LP bought a new position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 45,293 shares of the company's stock, valued at approximately $334,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. State of Wyoming increased its position in LifeStance Health Group by 33.5% during the 4th quarter. State of Wyoming now owns 37,823 shares of the company's stock valued at $279,000 after buying an additional 9,488 shares in the last quarter. ProShare Advisors LLC grew its stake in shares of LifeStance Health Group by 49.0% in the fourth quarter. ProShare Advisors LLC now owns 39,282 shares of the company's stock worth $290,000 after acquiring an additional 12,925 shares during the last quarter. Nuveen Asset Management LLC increased its holdings in shares of LifeStance Health Group by 34.2% during the fourth quarter. Nuveen Asset Management LLC now owns 422,475 shares of the company's stock valued at $3,114,000 after acquiring an additional 107,695 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of LifeStance Health Group by 2.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company's stock worth $1,023,000 after purchasing an additional 3,305 shares during the last quarter. Finally, Janus Henderson Group PLC raised its position in shares of LifeStance Health Group by 51.4% in the 4th quarter. Janus Henderson Group PLC now owns 59,500 shares of the company's stock worth $439,000 after purchasing an additional 20,200 shares during the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Stock Performance

Shares of LFST traded down $0.17 during trading hours on Friday, hitting $5.25. The stock had a trading volume of 1,265,582 shares, compared to its average volume of 1,603,496. The firm has a market capitalization of $2.04 billion, a PE ratio of -20.19 and a beta of 1.22. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. LifeStance Health Group, Inc. has a 12 month low of $4.64 and a 12 month high of $8.61. The stock has a fifty day moving average price of $6.17 and a 200 day moving average price of $7.03.

Analysts Set New Price Targets

Several brokerages have issued reports on LFST. KeyCorp assumed coverage on shares of LifeStance Health Group in a report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 target price for the company. Canaccord Genuity Group started coverage on LifeStance Health Group in a report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 target price for the company. UBS Group upgraded LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 price target for the company in a research note on Tuesday, May 27th. Finally, William Blair reaffirmed an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, LifeStance Health Group currently has a consensus rating of "Moderate Buy" and a consensus price target of $8.50.

Insider Buying and Selling at LifeStance Health Group

In related news, insider Lisa K. Miller sold 18,845 shares of the firm's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the transaction, the insider now directly owns 339,810 shares of the company's stock, valued at approximately $2,344,689. This trade represents a 5.25% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Ujjwal Ramtekkar sold 16,000 shares of LifeStance Health Group stock in a transaction on Thursday, June 5th. The shares were sold at an average price of $5.94, for a total value of $95,040.00. Following the transaction, the insider now owns 113,435 shares in the company, valued at $673,803.90. This trade represents a 12.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,859 shares of company stock worth $225,169 in the last three months. 3.20% of the stock is currently owned by company insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.